Trial NCT00818961

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000630617
Secondary IDs: BMTGG-NSH-756

Last trial update was posted on 2013-12-18

MeSH Interventions

Alemtuzumab Busulfan Cyclophosphamide Fludarabine Fludarabine phosphate Methotrexate Rituximab Tacrolimus

MeSH Conditions

Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Myeloproliferative Disorders Preleukemia

Other Conditions

Myelodysplastic/Myeloproliferative Diseases

Stopping Reasons

terminated early due to meeting end point with fewer patients than anticipated

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID